05 Jul 2022 ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder Member news
28 Jun 2022 MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis Member news
23 Jun 2022 Charles River and Ziphius Vaccines collaborate to manufacture saRNA-based vaccine Member news
22 Jun 2022 Biocartis announces new agreement with AstraZeneca for the development and marketing of a companion diagnostic test for Tagrisso® Member news
21 Jun 2022 Biotalys and Novozymes enter into partnership to expand opportunities for Evoca™ Member news
21 Jun 2022 New agreement paves way for development of first African-owned COVID-19 vaccine Member news
09 Jun 2022 Ziphius Vaccines and University of Antwerp announce collaboration agreement for optimized delivery of saRNA-based vaccines & therapeutics Member news
25 May 2022 CureVac partners with myNEO to identify novel antigen targets for mRNA-based cancer vaccine development Member news
18 May 2022 KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
